This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Lentiviral Vector as a Drug Product- a Gene Therapy Vector Facility Case Study

Lentiviral Vector as a Drug Product- a Gene Therapy Vector Facility Case Study

By | 16 January 2026

Introducing Kings College London's Gene Therapy Vector Facility
Manufacturing lentiviral vectors as a drug product
Highlighting GTVFs CDMO offerings